home / stock / ensc / ensc quote
Last: | $0.5586 |
---|---|
Change Percent: | -0.23% |
Open: | $0.5596 |
Close: | $0.5586 |
High: | $0.5698 |
Low: | $0.545 |
Volume: | 42,994 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.5586 | $0.5596 | $0.5586 | $0.5698 | $0.545 | 42,994 | 04-24-2024 |
$0.5583 | $0.55 | $0.5583 | $0.567999 | $0.541 | 43,894 | 04-23-2024 |
$0.541 | $0.59 | $0.541 | $0.59 | $0.5406 | 53,698 | 04-22-2024 |
$0.571 | $0.6075 | $0.571 | $0.6075 | $0.53 | 187,232 | 04-19-2024 |
$0.5802 | $0.6626 | $0.5802 | $0.6626 | $0.58 | 91,246 | 04-18-2024 |
$0.6298 | $0.68 | $0.6298 | $0.689 | $0.6003 | 115,068 | 04-17-2024 |
$0.6457 | $0.6666 | $0.6457 | $0.6698 | $0.631 | 67,187 | 04-16-2024 |
$0.6795 | $0.74 | $0.6795 | $0.74 | $0.627 | 249,807 | 04-15-2024 |
$0.744951 | $0.75 | $0.744951 | $0.7592 | $0.74 | 42,886 | 04-12-2024 |
$0.75375 | $0.77 | $0.75375 | $0.77 | $0.741 | 116,364 | 04-11-2024 |
$0.7823 | $0.785 | $0.7823 | $0.7955 | $0.76 | 82,969 | 04-10-2024 |
$0.78 | $0.7983 | $0.78 | $0.7983 | $0.7521 | 68,398 | 04-09-2024 |
$0.78 | $0.81 | $0.78 | $0.819 | $0.752 | 106,267 | 04-08-2024 |
$0.805 | $0.8133 | $0.805 | $0.8364 | $0.8027 | 79,814 | 04-05-2024 |
$0.843 | $0.81 | $0.843 | $0.8668 | $0.8026 | 223,195 | 04-04-2024 |
$0.8026 | $0.7857 | $0.8026 | $0.815 | $0.7802 | 65,803 | 04-03-2024 |
$0.81 | $0.809 | $0.81 | $0.8227 | $0.7801 | 98,085 | 04-02-2024 |
$0.78 | $0.78 | $0.78 | $0.8 | $0.7603 | 56,757 | 04-01-2024 |
$0.7902 | $0.8093 | $0.7902 | $0.813 | $0.751 | 125,780 | 03-29-2024 |
$0.7902 | $0.8093 | $0.7902 | $0.813 | $0.751 | 125,780 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc. Company Name:
ENSC Stock Symbol:
NASDAQ Market:
Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical Plans SAN DIEGO, CA / ACCESSWIRE / March 15, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage compa...